Clinical Trials
34 trialsNCT04513717 2026-05-04
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial
NRG Oncology
Phase 3 Active not recruiting
NCT05050084 2026-05-04
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
NRG Oncology
Phase 3 Active not recruiting
NCT04455750 2026-02-05
CASPAR
Alliance for Clinical Trials in Oncology
Phase 3 Active not recruiting
NCT04181203 2025-07-30
CARLHA-2
UNICANCER
Phase 3 Active not recruiting
NCT00223145 2025-01-27
PCS III
Université de Sherbrooke
Phase 3 Active not recruiting
NCT02344472 2024-06-04
Detect V / CHEVENDO (Chemo vs. Endo)
University of Ulm
Phase 3 Active not recruiting
NCT03664895 2023-12-04
Density Lowering Effect of "OFS Add on to TMX"(DELFINO Trial)
Seoul National University Hospital
Phase 3 Unknown
NCT05781217 2023-11-18
URONCOR 06-24
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic
Phase 3 Recruiting
NCT00541047 2023-11-13
RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery
University College, London
Phase 3 Completed
NCT03447132 2023-03-10
SAFIA
International Cancer Research Group, United Arab Emirates
Phase 3 Completed
NCT00430183 2023-02-09
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Active not recruiting
NCT00055731 2023-01-18
Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
UNICANCER
Phase 3 Completed
NCT02914158 2023-01-17
ASPAIT
First Affiliated Hospital, Sun Yat-Sen University
Phase 3 Unknown
NCT05439499 2022-07-06
This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.
Ahon Pharmaceutical Co., Ltd.
Phase 3 Unknown
NCT05438810 2022-07-05
This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c in Combination With Fluvestrant ± Goseraline Versus Placebo Combined With Fulvestrant ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.
Ahon Pharmaceutical Co., Ltd.
Phase 3 Unknown
NCT00116220 2022-01-06
Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer
Dana-Farber Cancer Institute
Phase 3 Completed
NCT02518191 2021-06-11
Effects of GnRHa on Ovarian Function Against Chemotherapy-induced-gonadotoxicity
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Phase 3 Completed
NCT00104715 2021-02-21
Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer
UNICANCER
Phase 3 Completed
NCT00303784 2020-11-27
PATCH
University College, London
Phase 3 Unknown
NCT00003645 2020-04-28
Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT02532400 2020-03-11
COMPETE
Ruijin Hospital
Phase 3 Terminated
NCT01638247 2018-09-19
MALE
GBG Forschungs GmbH
Phase 3 Completed
NCT00423475 2018-05-17
Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer
UNICANCER
Phase 3 Completed
NCT02483767 2017-10-17
POF
Peking Union Medical College Hospital
Phase 3 Completed
NCT01712893 2017-08-25
Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast Cancer
Fudan University
Phase 3 Completed
NCT00439751 2016-07-12
ELAAT
Ontario Clinical Oncology Group (OCOG)
Phase 3 Completed
NCT00429403 2016-05-09
Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT01530607 2016-02-25
Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
King Faisal Specialist Hospital & Research Center
Phase 3 Completed
NCT00067015 2015-12-22
Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 3 Completed
NCT00053911 2014-12-16
Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer
UNICANCER
Phase 3 Terminated
NCT02132390 2014-06-04
Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea
Peking Union Medical College Hospital
Phase 3 Unknown
NCT00388804 2012-08-08
External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT01581944 2012-04-20
Gonadotropin-releasing Hormone Agonist Prior to Myomectomy
Mt. Hope Maternity Hospital
Phase 3 Completed
NCT00912548 2009-06-16
ASTRRA
Korean Breast Cancer Study Group
Phase 3 Unknown